Aqueduct Medical to Present Outstanding Patient Results at Medtech Insight's ``Investment In Innovation'' Conference.SAN FRANCISCO San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden -- On June 14, 2005, Aqueduct aqueduct (ăk`wədŭkt) [Lat.,=conveyor of water], channel or trough built to convey water, chiefly for providing a densely populated region with a supply of freshwater. Medical, Inc. will present significant progress in bringing its innovative cosmetic surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. recovery products to market at Medtech Insight's prestigious "Investment In Innovation" event taking place June 14-15, 2005 at the Palace Hotel in San Francisco, California “San Francisco” redirects here. For other uses, see San Francisco (disambiguation). The City and County of San Francisco (EN IPA: [sænfrənˈsɪskoʊ] . Aqueduct will highlight the outstanding patient results achieved with their AqueShield(TM) Recovery System. Aqueduct is developing products based on patent-pending Controlled Cooling Technology(TM) that improve patient recovery from cosmetic and reconstructive surgery reconstructive surgery n. Plastic surgery. reconstructive surgery, n surgery to rebuild a structure for functional or esthetic reasons. . Initial patient results with the AqueShield(TM) have been outstanding, with patients consistently reporting a decrease in swelling, bruising bruising discoloration and actual hemorrhage at the site of injury, and a serious disadvantage in the meat trade. In the first 12 hours after injury the bruise is bright red, at 24 hours it is dark red, at 24 to 36 hours it loses its firm consistency and becomes watery and at 3 or , pain, and recovery time. "Aqueduct is bringing to market long overdue products that improve recovery for cosmetic and reconstructive surgery patients," says Dr. David Kaufman David Kaufman may be:
Aqueduct has an IRB-approved protocol and is beginning clinical testing to scientifically quantify the benefits to patients and their doctors. Aqueduct Medical expects to begin selling its AqueShield(TM) and AqueCool(TM) Recovery Systems in July 2005. Advisor Jerry Gibson, founder and former CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of DermaHealth, says, "The Aqueduct team has developed an innovative product that addresses a substantial market need. This product can deliver recovery assistance for both traditional cosmetic procedures as well as for the majority of the latest aesthetic technologies. This unique position allows Aqueduct to accelerate growth from investments in these latest product advancements." About Aqueduct Medical: Aqueduct Medical, Inc. is a privately held medical device start up located in San Francisco, CA. Founded in 2003, Aqueduct develops innovative patient care products for recovery from cosmetic and reconstructive surgery. For product and investment opportunity information please call Eric Selvik at (415) 543-5068. About Medtech Insight Medtech Insight's "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conferences are considered the premier forum for senior executives in the medical technology and investment community to preview emerging medtech companies in need of funding, acquisition and/or strategic partnership. In addition to conferences, Medtech Insight publishes the "medtech insight" newsletter, a monthly publication covering the latest trends and innovations in the medical technology industry, analyses of medtech markets through its Reports group, and offers custom consulting and market research. To register for the San Francisco conference or for more information on Medtech Insight, please call Scott Pantel at (949) 219-0150 or (888) 290-2225 toll-free in the U.S., e-mail in3@medtechinsight.com, or visit http://www.medtechinsight.com/in3-11.html. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion